
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression
Irene Y. Cheung, Nai‐Kong V. Cheung, Shakeel Modak, et al.
Journal of Clinical Oncology (2020) Vol. 39, Iss. 3, pp. 215-226
Open Access | Times Cited: 80
Irene Y. Cheung, Nai‐Kong V. Cheung, Shakeel Modak, et al.
Journal of Clinical Oncology (2020) Vol. 39, Iss. 3, pp. 215-226
Open Access | Times Cited: 80
Showing 1-25 of 80 citing articles:
Advancing therapy for neuroblastoma
Bo Qiu, Katherine K. Matthay
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 8, pp. 515-533
Closed Access | Times Cited: 218
Bo Qiu, Katherine K. Matthay
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 8, pp. 515-533
Closed Access | Times Cited: 218
Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives
Nora Berois, Álvaro Pittini, Eduardo Osinaga
Cancers (2022) Vol. 14, Iss. 3, pp. 645-645
Open Access | Times Cited: 74
Nora Berois, Álvaro Pittini, Eduardo Osinaga
Cancers (2022) Vol. 14, Iss. 3, pp. 645-645
Open Access | Times Cited: 74
High-Risk and Relapsed Neuroblastoma: Toward More Cures and Better Outcomes
Steven G. DuBois, Margaret E. Macy, Tara O. Henderson
American Society of Clinical Oncology Educational Book (2022), Iss. 42, pp. 768-780
Open Access | Times Cited: 72
Steven G. DuBois, Margaret E. Macy, Tara O. Henderson
American Society of Clinical Oncology Educational Book (2022), Iss. 42, pp. 768-780
Open Access | Times Cited: 72
Generation of anti-GD2 CAR macrophages from human pluripotent stem cells for cancer immunotherapies
Jue Zhang, Sarah Webster, Bret Duffin, et al.
Stem Cell Reports (2023) Vol. 18, Iss. 2, pp. 585-596
Open Access | Times Cited: 48
Jue Zhang, Sarah Webster, Bret Duffin, et al.
Stem Cell Reports (2023) Vol. 18, Iss. 2, pp. 585-596
Open Access | Times Cited: 48
Beta-glucan: An overview in biological activities, derivatives, properties, modifications and current advancements in food, health and industrial applications.
Great Iruoghene Edo, Winifred Ndudi, Raghda Makia, et al.
Process Biochemistry (2024)
Closed Access | Times Cited: 15
Great Iruoghene Edo, Winifred Ndudi, Raghda Makia, et al.
Process Biochemistry (2024)
Closed Access | Times Cited: 15
Cancer vaccines: platforms and current progress
Wanting Lei, Kexun Zhou, Ye Lei, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 2
Wanting Lei, Kexun Zhou, Ye Lei, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 2
Immunotherapy of Neuroblastoma: Facts and Hopes
John Anderson, Robbie G. Majzner, Paul M. Sondel
Clinical Cancer Research (2022) Vol. 28, Iss. 15, pp. 3196-3206
Open Access | Times Cited: 68
John Anderson, Robbie G. Majzner, Paul M. Sondel
Clinical Cancer Research (2022) Vol. 28, Iss. 15, pp. 3196-3206
Open Access | Times Cited: 68
Antitumor effect of soluble β-glucan as an immune stimulant
Lijuan Wu, Jun Zhao, Xiaonan Zhang, et al.
International Journal of Biological Macromolecules (2021) Vol. 179, pp. 116-124
Closed Access | Times Cited: 59
Lijuan Wu, Jun Zhao, Xiaonan Zhang, et al.
International Journal of Biological Macromolecules (2021) Vol. 179, pp. 116-124
Closed Access | Times Cited: 59
Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic Neuroblastoma
Gcf Chan, Carol Matias Chan
Biomolecules (2022) Vol. 12, Iss. 3, pp. 358-358
Open Access | Times Cited: 39
Gcf Chan, Carol Matias Chan
Biomolecules (2022) Vol. 12, Iss. 3, pp. 358-358
Open Access | Times Cited: 39
Membrane‐Fusion‐Mediated Multiplex Engineering of Tumor Cell Surface Glycans for Enhanced NK Cell Therapy
Chunxiong Zheng, Qingguo Zhong, Wantong Song, et al.
Advanced Materials (2022) Vol. 35, Iss. 14
Closed Access | Times Cited: 39
Chunxiong Zheng, Qingguo Zhong, Wantong Song, et al.
Advanced Materials (2022) Vol. 35, Iss. 14
Closed Access | Times Cited: 39
Immunomodulatory Effect and Biological Significance of β-Glucans
Xuemei Zhong, Guoqing Wang, Fu Li, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1615-1615
Open Access | Times Cited: 38
Xuemei Zhong, Guoqing Wang, Fu Li, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1615-1615
Open Access | Times Cited: 38
Metastasis pattern and prognosis in children with neuroblastoma
Shan Liu, Weimin Yin, Yaobin Lin, et al.
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 34
Shan Liu, Weimin Yin, Yaobin Lin, et al.
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 34
Variant rs8400 enhances ALKBH5 expression through disrupting miR-186 binding and promotes neuroblastoma progression
Qian Guan, Huiran Lin, Wenfeng Hua, et al.
Chinese Journal of Cancer Research (2023) Vol. 35, Iss. 2, pp. 140-162
Open Access | Times Cited: 34
Qian Guan, Huiran Lin, Wenfeng Hua, et al.
Chinese Journal of Cancer Research (2023) Vol. 35, Iss. 2, pp. 140-162
Open Access | Times Cited: 34
Biology of GD2 ganglioside: implications for cancer immunotherapy
Pierre Machy, Erwan Mortier, Stéphane Birklé
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 26
Pierre Machy, Erwan Mortier, Stéphane Birklé
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 26
The biological role and immunotherapy of gangliosides and GD3 synthase in cancers
Shangqi Cao, Xu Hu, Shangqing Ren, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 23
Shangqi Cao, Xu Hu, Shangqing Ren, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 23
GD2-targeting therapy: a comparative analysis of approaches and promising directions
Julia Philippova, Julia Shevchenko, С. В. Сенников
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Julia Philippova, Julia Shevchenko, С. В. Сенников
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Vaccine adjuvants: current status, research and development, licensing, and future opportunities
Ying Cui, Megan Ho, Yongjie Hu, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 17, pp. 4118-4137
Open Access | Times Cited: 10
Ying Cui, Megan Ho, Yongjie Hu, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 17, pp. 4118-4137
Open Access | Times Cited: 10
Targeting macrophages in cancer immunotherapy: Frontiers and challenges
Yue Liu, Huabing Tan, Jingyuan Dai, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1
Yue Liu, Huabing Tan, Jingyuan Dai, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1
Aspects of Phage-Based Vaccines for Protein and Epitope Immunization
Marco Palma
Vaccines (2023) Vol. 11, Iss. 2, pp. 436-436
Open Access | Times Cited: 19
Marco Palma
Vaccines (2023) Vol. 11, Iss. 2, pp. 436-436
Open Access | Times Cited: 19
Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors
Yasuyuki Matsumoto, Tongzhong Ju
Cancers (2023) Vol. 15, Iss. 14, pp. 3536-3536
Open Access | Times Cited: 19
Yasuyuki Matsumoto, Tongzhong Ju
Cancers (2023) Vol. 15, Iss. 14, pp. 3536-3536
Open Access | Times Cited: 19
Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy
Tianqi Wang, Yusuke Suita, Saradha Miriyala, et al.
Pharmaceutics (2021) Vol. 13, Iss. 4, pp. 520-520
Open Access | Times Cited: 38
Tianqi Wang, Yusuke Suita, Saradha Miriyala, et al.
Pharmaceutics (2021) Vol. 13, Iss. 4, pp. 520-520
Open Access | Times Cited: 38
Bioactive sphingolipids as emerging targets for signal transduction in cancer development
Wentao Jia, Jiaying Yuan, Jinbo Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189176-189176
Closed Access | Times Cited: 5
Wentao Jia, Jiaying Yuan, Jinbo Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189176-189176
Closed Access | Times Cited: 5
Tumor Glycosylation: A Main Player in the Modulation of Immune Responses
Ernesto Rodríguez
European Journal of Immunology (2025) Vol. 55, Iss. 3
Open Access
Ernesto Rodríguez
European Journal of Immunology (2025) Vol. 55, Iss. 3
Open Access
Plant-Derived Immunomodulatory Nanoadjuvants for Cancer Vaccines: Current Status and Future Opportunities
Yingli Jia, Hui Zhu, Xinyu Cai, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 378-378
Open Access
Yingli Jia, Hui Zhu, Xinyu Cai, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 378-378
Open Access
Chemoenzymatic Synthesis of 9NHAc‐GD2 Antigen to Overcome the Hydrolytic Instability of O‐Acetylated‐GD2 for Anticancer Conjugate Vaccine Development
Xuanjun Wu, Jinfeng Ye, Andrew T. DeLaitsch, et al.
Angewandte Chemie International Edition (2021) Vol. 60, Iss. 45, pp. 24179-24188
Open Access | Times Cited: 28
Xuanjun Wu, Jinfeng Ye, Andrew T. DeLaitsch, et al.
Angewandte Chemie International Edition (2021) Vol. 60, Iss. 45, pp. 24179-24188
Open Access | Times Cited: 28